BARCLAY A PHILLIPS

CIK 1265801 · SVP & Chief Financial Officer · last filed 2025-06-09

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$343.4K

Companies

5

Total Filings

43

Lifetime Open-Market Net

-$7.70M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
IMUX Director $13.86 $0 8 2025-06-09
G1 Therapeutics, Inc. (GTHX) Delisted SVP & Chief Financial Officer 5,000 $7.15 $35.8K -$199.6K 3 2019-01-02
NVAX SVP, Chief Financial Officer 38,669 $8.88 $343.4K -$167.1K 19 2017-08-01
MICROMET, INC. (MITI) Delisted SVP, CFO 0 -$213.6K 9 2012-03-06
Acorda Therapeutics, Inc. (ACOR) Delisted Director 333,419 $0.66 $220.4K -$7.12M 3 2008-06-16

Recent Filings · Page 5 of 5

43 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2008-05-23 Acorda Therapeutics, Inc. (ACOR) Delisted Grant (A) $0 EDGAR
2007-08-07 Acorda Therapeutics, Inc. (ACOR) Delisted Grant (A) $0 EDGAR
2007-07-23 MICROMET, INC. (MITI) Delisted Grant (A) $0 EDGAR
Showing 4143 of 43
Page 5 of 5
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.